chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient reports she spent substantial amount of time outdoors and began having a wheeze.  Over the course of the last 2 days, her wheeze has become more persistent and she is not making it for hours between albuterol treatments at home.  She is not using a spacer.  She denies any frank chest pain but does endorse some chest tightness.  She denies any fevers or chills.  She reports she does have some sputum production.  She denies any hemoptysis.  She denies any pleurisy.  Her Abbott rapid coronavirus test was positive here in the emergency room.
Approx 11 hours after admin. pt woke up went to parent's room disoriented. Collapsed to floor. Was not responsive for 2-5 min and was incontinent of urine & stool. She had a period of about 8 minute afterward where she was less responsive pt possibly postictal.
Severe swelling, arm was erythematous and hot. Patient went to local Emergency Room. Was given Ibuprofen and codeine.
This spontaneous case was reported by a consumer and describes the occurrence of COUGH (dry cough), CHEST DISCOMFORT (chest tightness), FEELING ABNORMAL (feels bad), PAIN (achiness) and PYREXIA (fever) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No relevant concomitant medications reported No relevant medical history was reported.    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 28-Feb-2021, the patient experienced COUGH (dry cough), CHEST DISCOMFORT (chest tightness), FEELING ABNORMAL (feels bad), PAIN (achiness), PYREXIA (fever) and FATIGUE (fatigue). On 01-Mar-2021, PAIN (achiness) and PYREXIA (fever) had resolved. At the time of the report, COUGH (dry cough), CHEST DISCOMFORT (chest tightness), FEELING ABNORMAL (feels bad) and FATIGUE (fatigue) outcome was unknown.            Treatment Medications were not provided by the reporter.
A red, blotchy rash developed on forearms and then spread to the trunk of my body. The rash extended from my neck all the way to my knees.  Rash was sensitive to the touch and felt somewhat like a sunburn.
Increased heart rate/ palpitations within 2 minutes of receiving vaccine that lasted approximately 20 minutes
Patient's mother states he had reaction to Td given Thursday 4/12/07, started Friday - fever, dizziness, localized swelling and redness in left deltoid, fatigue. Seen in ER 4/14 - ultrasound (-) fn abscess. S/S include chills, fever.  WBC WNL. 4/16 Mild residual occipital HA, left deltoid mildly sore "like a bruise", and erythema. Rec'd Tylenol, Amoxicillin at ER.
sore arm, tender at injection site; sore arm, tender at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm, tender at injection site) and VACCINATION SITE PAIN (sore arm, tender at injection site) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Patient's medical history included No Adverse event.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1. On 27-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm, tender at injection site) and VACCINATION SITE PAIN (sore arm, tender at injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm, tender at injection site) and VACCINATION SITE PAIN (sore arm, tender at injection site) outcome was unknown.            Relevant concomitant product usage were not reported by the reporter.  Action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to MOD-2021-054855, MOD-2021-054651, MOD-2021-054855 (Patient Link).
This spontaneous report was received from a nurse refers to an unspecified patient of unknown demographics. The patient's concurrent condition, medical history, drug reactions/allergies and concomitant medications were not reported. On 10-APR-2018, the patient was inadvertently vaccinated with an expired dose of VAQTA (dose, frequency, route and lot # were not reported) expiry date: 08-APR-2018 for prophylaxis (expired product administered). No adverse effects were reported. This is a non-valid report due to lack of patient identifiers. Upon receipt of follow-up information it was determined that this case is now valid because patient identifier was received. Follow up information has been received from the registered nurse on 24-APR-2018, concerning the 19 years old male patient who was vaccinated with an expired dose of, also it was reported VAQTA (lot # N005605 was administrated by intramuscular route), it was his first dose. None illness at the time of vaccination, either pre-existing physician-diagnosed allergies, birth defects nor medical conditions were reported.
Diarrhea and vomiting after Dose 1. Sore arm, decreased energy, and queasy after Dose 2.
Information has been received from a physician's assistant concerning a 11 year old female who on unspecified date was vaccinated intramuscularly with HPV rL1 6 11 16 18 VLP vaccine (yeast) (Lot# not provided). Subsequently the patient developed swollen lymph nodes in groin her area. Unspecified medical attention was sought. Additional information has been requested.
1. lump found in same exact location where anthrax vaccine was given. Surgery performed. Patch, blood clot: August 2003. 2. Lump no. 2 location: second surgery, patch, crust. Per the subject's mother: her son developed a blood clot in the bicep of the same arm as the shot was given. The clot was surgically removed as an outpt in Aug03. A suspected second clot developed in the tricep of the same arm, which was surgically removed as an outpt in Jan2004. The pathology report after the second surgery came back as a benign tumor. The subject has received 5 doses of AVA with the following lot information. Dec 17, 2002 FAV966, Jan 3, 2003 FAV067, Jan 20,2003 FAV066, Sep 22, 2003 FAV079, Mar 16, 2004 FAV068. This report is linked to VAERS226832 which was submitted by the subject's mother.
Pain in their legs; Pain in their knees; Constant muscular pain from their waist down; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in their legs), ARTHRALGIA (Pain in their knees) and MYALGIA (Constant muscular pain from their waist down) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026021a) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jun-2021, the patient experienced PAIN IN EXTREMITY (Pain in their legs). 29-Jun-2021, the patient experienced ARTHRALGIA (Pain in their knees) and MYALGIA (Constant muscular pain from their waist down). The patient was treated with ACETAMINOPHEN for Pain, at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) for Pain, at a dose of 15 milligram. At the time of the report, PAIN IN EXTREMITY (Pain in their legs), ARTHRALGIA (Pain in their knees) and MYALGIA (Constant muscular pain from their waist down) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient reported that she was not taking any concomitant medications.
pain at injection site from first dose; This is a spontaneous report from a contactable Nurse (patient).   A 53-year-old female patient received the 1st dose of bnt162b2 (BNT162B2, Lot # either EJ7685 or EJ1685) at single dose at right deltoid on 30Dec2020 for Covid-19 immunisation.  Medical history included gluten sensitivity and developed a rash when she ate gluten. The patient's concomitant medications were not reported.  The patient experienced pain at injection site from 1st dose on 31Dec2020. The outcome of event was recovered on 02Jan2021.   Information about Batch/Lot number has been requested.
Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: Patient noticed a half-dollar sized lump/red area that is hot to touch and gradually grew to palm-sized lump/red area below injection site, told patient to monitor and if it gets any worse or other symptoms persisted to follow up with PCP or ER depending on symptoms.
24-48 hours post injection, pt experienced a sore arm consistent with other immunizations which resolved shortly thereafter.   9 days post immunization, pt experienced pain and inflammation in the area of the injection. Symptoms included radiating pain into the scapular area, mimicking that of a labral tear. Pt continues to experience pain/inflammation at the site of the injection that continues to radiate and feels like a fatigued arm with excessive movement (as of today (Day 14)).
full ache at the site of the shot; prickly sensations in hand and finger tips; left harm has gone numb randomly three times; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 24Mar2021 at 09:45 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021, the patient experienced numbness of upper arm. On 31Mar2021, the patient experienced prickling of hand. On 08Apr2021, the patient experienced vaccination site pain. Its reported that his left arm had gone numb randomly three times since the vaccine. The first time was while sleeping about 3 days following shot. He was not sleeping on the arm at the time and could find no logical explanation for the sudden numbness. The second time was while driving home 7 days following the shot. His arm suddenly went numb and had prickly sensations in hand and finger tips. The third time was 08Apr2021, 15 days following shot. The numbness was sudden and went away within 60 seconds but the prickly had persisted. There was also a full ache at the site of the shot. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event of numbness of upper arm was recovered with sequelae on an unknown date in Apr2021 while the clinical outcome of the event of prickling of hand was not recovered at the time of this report and the clinical outcome of the event of vaccination site pain was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
lip swelled; throat swelled; had a funny feeling in the chest; Initial information received on 25-Oct-2023 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp.  This case is linked to cases 2023SA336263 and 2023SA325293.  This case involves a female patient of an unknown age who experienced lip swelled, throat swelled and had a funny feeling in the chest after receiving Influenza Quadrival A-B Vaccine [Fluzone Qiv].  The patient's past vaccination(s) included COVID shot. The patient's past medical history, medical treatment(s) and family history were not provided.   On an unknown date in 2009, the patient received a unknown dose of suspect Influenza Quadrival A-B Vaccine (strength, expiry date and lot number not reported) via unknown route in unknown administration site as Prophylactic vaccination (immunization). Information on the batch number was requested.  On an unknown date the patient developed lip swelled (lip swelling), throat swelled (pharyngeal swelling) and had a funny feeling in the chest (chest discomfort) (unknown latency).  Action taken: not applicable.  An allergy medication in a larger quantity for 7-days was received as corrective treatment for the events (lip swelled, throat swelled) and It was not reported if the patient received a corrective treatment for the event (had a funny feeling in the chest).  At time of reporting, the outcome was Unknown for all events
Shoulder site pain for 48 hours. Moving pain into shoulder and down into elbow joint. Severe elbow and shoulder pain that interferes with daily function. This began within 24 hours and persists 19 days later. Within in 72 hours of shot I have experienced chest pressure, heart palpitations and discomfort.
Information has been received from a physician concerning a 9 year old male with no known medical history or allergies who on 09-DEC-1997 was vaccinated SC in the left thigh with a first dose of Varivax (lot # 623135/0689E). Concomitant vaccination included a SC first dose in the right thigh of MMR II (lot # 622737/0739E). There was no illness at the time of vaccination. On 15-JUL-2006 (also reported as 17-JUL-2006) the patient developed many pox (rash) on back and chest. Medical attention was not sought. The patient recovered on 24-JUL-2006. Additional information has been requested.
kinda sick (after first dose); This spontaneous case was reported by a patient and describes the occurrence of MALAISE (kinda sick (after first dose)) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Congestive heart failure. Concomitant products included LISINOPRIL, NAPROXEN and METOPROLOL (CORVITOL [METOPROLOL]) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (kinda sick (after first dose)). At the time of the report, MALAISE (kinda sick (after first dose)) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Blood thinners, 2 diuretics and six pills a day were also reported as concomitant medications. No treatment medications were reported.   This case was linked to MOD-2021-319932 (Patient Link).
Scratchy throat that progressed to a persistent cough and auditory wheeze upon inhalation.
Patient vomited 1 time that evening, approximately 7 hours after administration of the flu vaccine. Had no other signs of illness. Mom reported that patient was "fine" the next day but wanted reported to VAERS.
after 2 vaccinations and 2 boosters (Moderna) (4/4/22 forth shot) I self tested positive for COVID on May 26. I received a Monoclonal Infusion 2 days later. I now feel fine.
Mom reports child woke up 4/14/17 with fever of 101 F. Headache, stomach ache, legs hurting and "can't see". Advised to take to Dr or urgent care clinic. Parent took him to ER. Temp was 101 F. Mom says ER physician suspected strep or influenza (both tests negative). 4/17/17 spoke to mom, child doing fine.
RNs notified that by CMA that patient was experiencing sweating, dizziness after administration of flu vaccine.  RN exam-patient was pale, pulse steady. Notified PCP re: diaphoretic, pale, reporting dizziness.   Assessed orientation, denied difficulty breathing or chest pain. patient reported prior vasovagal episodes post blood draws.    Patient became extremely diaphoretic, head began nodding back. Responded to verbal stimulation. PERRLA. Denied difficulty breathing or chest pain. Answered all RN questions appropriately. Weak bilateral grip strength. Drank apple juice. VS assessed throughout, PCP present and recommended patient returned to supine position, patient reporting blurred vision/weakness. Transferred to low bed. CBG checked, EKG completed. BP taken. MDs reviewed EKG, reassessed patient. Pt ambulated around clinic RN to confirm gait stability; pt had no impairment to gait, oriented to person, place, time. Denies CP, AMS, difficulty breathing, visual changes/disturbances, diaphoresis/pallor subsided. Patient discharged home.
This spontaneous  report as received from a healthcare worker refers to a 62 year old male patient with hyperlipidemia, high uric acid count, arrythmia and no drug reaction or allergy. On 18-JUN-2013 the patient was vaccinated with PNEUMOVAX23 0.5ml, (lot number H017759, expiration date 04-JULY-2014, route not specified). Concomitant therapies included alprazolam, simvastatin (manufacturer unknown), PRILOSEC, and aspirin. On 19-JUN-2013 the patient developed muscle pain, swelling at the injection site and redness after receiving PNEUMOVAX23. The reported stated that symptoms lasted about three days. None of lab diagnostics studies was performed. The patient did not sought medical attention. The outcome of the events was reported as recovered/resolved on 22-JUN-2013. Relatedness between therapy with PNEUMOVAX23 and events was not reported. This is one of several reports from the same source (report from the same reporter MARRS#1307USA002309). Additional information has been requested.
Gradual onset and worsening of bruise starting at the site of injection then spreading distally to elbow.
ADR occurred in covid vaccination clinic 3/25/21. PT presented to ER for evaluation on 3/25/21 after receiving their 2nd dose of Pfizer covid vaccine received on 3/25/21. PT stated they developed mild lightheadedness and ?felt like their lungs were shutting down?. Patient felt short of breath briefly that started to resolve by the time they presented to ER but still felt short of breath. ER documentation stated on reassessment after labs, imaging and EKG, symptoms completely resolved.  PT was discharged same day with instruction to return if any symptoms return. Pfizer Dose 1 LOT# EL9264, dose 2 LOT# EN6204.
horrible sore throat with white spots & red, like strep throat; horrible sore throat with white spots & red, like strep throat; Sore on side of tongue; tired/ fatigue; no energy; body aches; pain in opposite right arm; itching in opposite right arm/ Redness and slight swelling, itchiness at first injection; Redness and slight swelling, itchiness at first injection; Redness and slight swelling, itchiness at first injection; This is a spontaneous report from a contactable Other-HCP (patient). A 59-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in arm left on 17Mar2021 (at the age of 59-years-old) as dose 1, single for COVID-19 immunisation. Medical history included asthma, known allergies: Penicillin and shellfish. The patient's concomitant medications were not reported. The patient previously took Aleve, Novocaine and septocaine and experienced known allergies. The patient was not pregnant at time of vaccination. Th patient was not received other vaccine in four weeks. The patient was not received covid prior vaccination. The patient has not been tested covid post vaccination. On 17Mar2021, after first dose, the patient had horrible sore throat with white spots & red, like strep throat. The patient had Sore on side of tongue, gone in 2 days. Tired, no energy, fatigue, body aches through out. On an unknown date in Mar2021 (1 week later), the patient had pain, itching in opposite right arm exactly where shot was given in left arm. Redness and slight swelling, itchiness at first injection. The patient did not receive treatment for all events. The outcome of the event of Sore on side of tongue was recovered on 19Mar2021 and other events was recovering.  The lot number for the vaccine, bnt162b2 was not provided and will be requested during follow up.
EXPIRED VACCINE ADMINISTERED; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 203A21A, expiry: 21-SEP-2021) dose was not reported, administered on 22-SEP-2021 for prophylactic vaccination. No concomitant medications were reported.  On 22-SEP-2021, the patient experienced expired vaccine administered. The action taken with covid-19 vaccine was not applicable. The outcome of expired vaccine administered was not reported. This report was non-serious.
received dose from expired vial; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received dose from expired vial) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 050E21A, 026L20A and 031M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (received dose from expired vial). At the time of the report, EXPIRED PRODUCT ADMINISTERED (received dose from expired vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment medication was reported.
About 10 minutes after she received the flu vaccine on 9/28/2020, the patient returned to the pharmacy counter complaining of a severe lower back pain that she described as "stabbing."  We had her remain seated and our floater pharmacist gave her a cold pack to place on her back.  After remaining seated for about 10-15 minutes, her back pain was starting to feel better enough for her to stand up and walk out of the store.  Her neighbor picked her up since she was unsure if she could drive home, and we recommended she follow up with the emergency department or her primary care physician.
Flu vaccination given approx 11:15 AM in Rt deltoid. No pain or redness at injection site. Onset of symptoms 13:30: tightness in chest, dizziness, finger and toes had tingling. 14:15: coughing, trouble breathing. Vitals by school nurse: BP 117/80 90 BPM, O2 saturation 99% BENADRYL given.
arm hurt for two days; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm hurt for two days) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (arm hurt for two days). At the time of the report, VACCINATION SITE PAIN (arm hurt for two days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Concomitant medication information was not provided by the reporter.                            Treatment information was not provided by the reporter.
Patient received the covid Moderna vaccine on 05/14/2021 but was accidently/incorrectly given Pfizer covid vaccine on 07/17/2021 as her second dose. no reported adverse reaction occurred.